Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3852641 | 1.00 | HTT (0.39) | HTTALDH1A1TSHRFGFR4 | |
| SCHEMBL3852636 | 1.00 | HTT (0.39) | HTTALDH1A1TSHRFGFR4 | |
| SCHEMBL10644907 | 0.86 | HTT (0.44) | HTTALDH1A1TSHRFGFR4 | |
| SCHEMBL1416684 | 0.83 | ALDH1A1 (0.37) | HTTALDH1A1TSHR | |
| SCHEMBL3854199 | 0.83 | ALDH1A1 (0.37) | HTTALDH1A1TSHR | |
| SCHEMBL1416683 | 0.83 | ALDH1A1 (0.37) | HTTALDH1A1TSHR | |
| Hydrogen Sulfide SCHEMBL27650551 | 0.81 | ALDH1A1 (0.36) | HTTALDH1A1TSHR | |
| SCHEMBL27514629 | 0.79 | ALDH1A1 (0.35) | HTTALDH1A1TSHR | |
| Hydrochloric Acid SCHEMBL29157016 | 0.75 | CYP2C19 (0.33) | ALDH1A1TSHR | |
| SCHEMBL9249182 | 0.74 | HTT (0.36) | HTTALDH1A1TSHRFGFR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1686114-B1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE 2-ALKYLCYSTEINE, DERIVATIVE THEREOF, AND PROCESSES FOR PRODUCTION | MITSUBISHI GAS CHEMICAL CO (JP) | 2009-10-07 | — | — | EP | claimed |
| US-7470525-B2 | Process for producing optically active 2-alkycysteine, derivative thereof, and processes for production | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2008-12-30 | — | — | US | claimed |
| US-20070037260-A1 | allowing cells of microorganism or treated products thereof having an activity of stereoselective hydrolysis of the amide bond of a 2-alkyl-L-cysteinamide or a salt thereof to act on a 2-alkylcysteinamide consisting of a mixture of D- and L-isomers or a salt thereof | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2007-02-15 | — | — | US | claimed |
| EP-1686114-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE 2-ALKYLCYSTEINE, DERIVATIVE THEREOF, AND PROCESSES FOR PRODUCTION | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2006-08-02 | — | — | EP | claimed |
| EP-1686114-B1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE 2-ALKYLCYSTEINE, DERIVATIVE THEREOF, AND PROCESSES FOR PRODUCTION | MITSUBISHI GAS CHEMICAL CO (JP) | 2009-10-07 | — | — | EP | disclosed |
| EP-1686114-B1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE 2-ALKYLCYSTEINE, DERIVATIVE THEREOF, AND PROCESSES FOR PRODUCTION | MITSUBISHI GAS CHEMICAL CO (JP) | 2009-10-07 | — | — | EP | disclosed |
| US-20090030210-A1 | Process for Producing Optically Active 2-Alkylcysteine, Derivative Thereof, and Processes for Production | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2009-01-29 | — | — | US | disclosed |
| US-20090030210-A1 | Process for Producing Optically Active 2-Alkylcysteine, Derivative Thereof, and Processes for Production | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2009-01-29 | — | — | US | disclosed |
| US-7470525-B2 | Process for producing optically active 2-alkycysteine, derivative thereof, and processes for production | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2008-12-30 | — | — | US | disclosed |
| US-7470525-B2 | Process for producing optically active 2-alkycysteine, derivative thereof, and processes for production | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2008-12-30 | — | — | US | disclosed |
| EP-1686114-A4 | PROCESS FOR PRODUCING OPTICALLY ACTIVE 2-ALKYLCYSTEINE, DERIVATIVE THEREOF, AND PROCESSES FOR PRODUCTION | MITSUBISHI GAS CHEMICAL CO (JP) | 2007-08-15 | — | — | EP | disclosed |
| US-20070037260-A1 | allowing cells of microorganism or treated products thereof having an activity of stereoselective hydrolysis of the amide bond of a 2-alkyl-L-cysteinamide or a salt thereof to act on a 2-alkylcysteinamide consisting of a mixture of D- and L-isomers or a salt thereof | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2007-02-15 | — | — | US | disclosed |
| US-20070037260-A1 | allowing cells of microorganism or treated products thereof having an activity of stereoselective hydrolysis of the amide bond of a 2-alkyl-L-cysteinamide or a salt thereof to act on a 2-alkylcysteinamide consisting of a mixture of D- and L-isomers or a salt thereof | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2007-02-15 | — | — | US | disclosed |
| EP-1686114-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE 2-ALKYLCYSTEINE, DERIVATIVE THEREOF, AND PROCESSES FOR PRODUCTION | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2006-08-02 | — | — | EP | disclosed |
| EP-1686114-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE 2-ALKYLCYSTEINE, DERIVATIVE THEREOF, AND PROCESSES FOR PRODUCTION | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2006-08-02 | — | — | EP | disclosed |
| JP-2006008556-A | METHOD FOR PRODUCING OPTICALLY ACTIVE THIAZOLIDINE-4-CARBOXYLIC ACID AMIDE OR SALT THEREOF | MITSUBISHI GAS CHEM CO INC | 2006-01-12 | — | — | JP | disclosed |
| JP-2006000006-A | METHOD FOR PRODUCING OPTICALLY ACTIVE 2-ALKYL-D-CYSTEINE ESTER | MITSUBISHI GAS CHEM CO INC | 2006-01-05 | — | — | JP | disclosed |
| JP-2006000005-A | METHOD FOR PRODUCING OPTICALLY ACTIVE 2-ALKYL-D-CYSTEINE OR ITS SALT | MITSUBISHI GAS CHEM CO INC | 2006-01-05 | — | — | JP | disclosed |
| JP-2005170794-A | OPTICALLY ACTIVE 2-ALKYL-D-CYSTEINEAMIDE OR ITS SALT AND METHOD FOR PRODUCING THESE COMPOUNDS | MITSUBISHI GAS CHEM CO INC | 2005-06-30 | — | — | JP | disclosed |
| WO-2005049557-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE 2-ALKYLCYSTEINE, DERIVATIVE THEREOF, AND PROCESSES FOR PRODUCTION | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2005-06-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090030210-A1 | Process for Producing Optically Active 2-Alkylcysteine, Derivative Thereof, and Processes for Production | AADAT, CBS, CTH | HTT 1136/4885ALDH1A1 444/4885TSHR 4348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.